FR09C0047I2 - Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation - Google Patents

Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation

Info

Publication number
FR09C0047I2
FR09C0047I2 FR09C0047C FR09C0047C FR09C0047I2 FR 09C0047 I2 FR09C0047 I2 FR 09C0047I2 FR 09C0047 C FR09C0047 C FR 09C0047C FR 09C0047 C FR09C0047 C FR 09C0047C FR 09C0047 I2 FR09C0047 I2 FR 09C0047I2
Authority
FR
France
Prior art keywords
carbonhydrates
immunogenic
soluble
activated
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR09C0047C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Found For T
Original Assignee
Henry M Jackson Found For T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/408,717 external-priority patent/US5651971A/en
Priority claimed from PCT/US1996/004013 external-priority patent/WO1996029094A1/en
Publication of FR09C0047I1 publication Critical patent/FR09C0047I1/fr
Application filed by Henry M Jackson Found For T filed Critical Henry M Jackson Found For T
Application granted granted Critical
Publication of FR09C0047I2 publication Critical patent/FR09C0047I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
FR09C0047C 1995-03-22 2009-09-24 Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation Active FR09C0047I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/408,717 US5651971A (en) 1993-09-22 1995-03-22 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
US48266195A 1995-06-07 1995-06-07
PCT/US1996/004013 WO1996029094A1 (en) 1995-03-22 1996-03-22 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents

Publications (2)

Publication Number Publication Date
FR09C0047I1 FR09C0047I1 (enExample) 2009-06-11
FR09C0047I2 true FR09C0047I2 (fr) 2017-03-17

Family

ID=41360971

Family Applications (1)

Application Number Title Priority Date Filing Date
FR09C0047C Active FR09C0047I2 (fr) 1995-03-22 2009-09-24 Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation

Country Status (5)

Country Link
JP (1) JP5594612B2 (enExample)
KR (1) KR100417183B1 (enExample)
DE (2) DE122009000055I1 (enExample)
FR (1) FR09C0047I2 (enExample)
NL (2) NL300414I1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2784144C (en) * 2009-12-17 2017-07-11 Fina Biosolutions, Llc Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE343210B (enExample) * 1967-12-20 1972-03-06 Pharmacia Ab
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
DE3541186A1 (de) * 1985-11-21 1987-05-27 Boehringer Mannheim Gmbh Wasserloesliche, stabilisierte peroxidasederivate, verfahren zu ihrer herstellung und verwendung zur bestimmung von wasserstoffperoxid
NZ236050A (en) * 1989-11-15 1993-04-28 Sandoz Ltd Water soluble conjugate of a polymyxin and a carrier
ATE198834T1 (de) * 1991-03-12 2001-02-15 Us Health Konjugate bestehend aus polysaccharid und protein
ES2204900T3 (es) * 1992-02-11 2004-05-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine Estructura inmuinogena de doble vector.
AU5741794A (en) * 1992-12-07 1994-07-04 Magainin Pharmaceuticals, Inc. Treatment of septic shock with conjugated biologically active peptides

Also Published As

Publication number Publication date
NL300414I1 (nl) 2009-12-01
NL300413I1 (nl) 2009-12-01
KR100417183B1 (ko) 2004-05-31
DE122009000056I1 (de) 2010-01-28
FR09C0047I1 (enExample) 2009-06-11
JP2012116850A (ja) 2012-06-21
KR19980703201A (ko) 1998-10-15
JP5594612B2 (ja) 2014-09-24
DE122009000055I1 (de) 2009-12-31

Similar Documents

Publication Publication Date Title
DE69529748D1 (de) Polynukleotide vakzine gegen den papilloma virus
HUP0004853A3 (en) Hepatitis c inhibitor peptides, process for preparation thereof, pharmaceutical compositions comprising thereof, their use and their intermediates
HUP9802199A1 (hu) Poliszacharid antigén-vivőprotein konjugátumot és szabad vivőproteint tartalmazó oltóanyag és alkalmazása
ES2181799T3 (es) Conjugados de acidos peptido nucleicos.
FI963786L (fi) Uusia 1,4-disubstituoituja piperidiinijohdannaisia, jotka ovat käyttökelpoisia glutamaattireseptoriin vaikuttavina lääkeaineina
NZ333226A (en) Immunstimulating lipid formulation
FI970247A7 (fi) Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitova n proteiinin
FR09C0047I2 (fr) Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation
EE200000129A (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
HRP990341B1 (en) Process for the preparation of mometasone furoate
IL114501A0 (en) Marek's disease virus vaccine
FR2645878B1 (fr) Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
MX9603124A (es) Vacuna contra el virus de la enfermedad de newcastle benigna.
FR2676068B1 (fr) Souches recombinantes immunogenes de b. anthracis - compositions immunogenes les contenant.
PT84399B (en) Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate
ITBO970139A0 (it) Dispositivo per l'impilamento di gruppi di prodotti selezionati da imp acchettare.
HUP9802568A3 (en) Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists and pharmaceutical compositions containing them
BR9602719A (pt) Virus da doença de Merek (MDV sorotipo 1) CEPA I-1585 de MDV vacina para a proteção de aves contra a doença de merek e processo para o desenvolvimento do MDV
RU97120940A (ru) Пептид, обладающий иммуномодулирующей активностью, и препарат на его основе
AU630186B2 (en) Canine corona virus vaccine
FR2731355B1 (fr) Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
FR2582662B1 (fr) Nouvelles compositions a base de derives de silice modifiee par des groupements organiques, leur preparation et leur application
HUP9602637A2 (en) 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives, producing and using them and fungicid compositions containing them
KR910009723A (ko) 4-카르바모일-1-β-D-리보푸라노실 이미다졸륨-5-올레이트 무수결정
IT1276509B1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.